Press Releases

All Releases
View Summary BG Medicine, Inc. Welcomes Presentation of Clinical Data on Galectin-3 Testing at the American Heart Association 2014 Scientific Sessions Conference
Nov 20, 2014
PDF 19.0 KB Add to Briefcase
View Summary BG Medicine Reports Third Quarter 2014 Financial Results
Nov 13, 2014
PDF 29.8 KB Add to Briefcase
View Summary BG Medicine Announces Q3 2014 Financial Results Release Date and Conference Call Information
Nov 7, 2014
PDF 13.8 KB Add to Briefcase
View Summary BG Medicine Reports Second Quarter 2014 Financial Results
Aug 14, 2014
PDF 26.3 KB Add to Briefcase
View Summary BG Medicine Announces Q2 2014 Financial Results Release Date and Conference Call Information
Aug 7, 2014
PDF 13.6 KB Add to Briefcase
View Summary BG Medicine Reports First Quarter 2014 Financial Results
May 14, 2014
PDF 28.3 KB Add to Briefcase
View Summary BG Medicine Announces Q1 2014 Financial Results Release Date and Conference Call Information
May 7, 2014
PDF 13.4 KB Add to Briefcase
View Summary BG Medicine, Inc. Prices $10.0 Million Public Offering of Common Stock
Apr 3, 2014
PDF 19.4 KB Add to Briefcase
View Summary BG Medicine, Inc. Announces Proposed Public Offering of Common Stock
Apr 2, 2014
PDF 19.0 KB Add to Briefcase
View Summary Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure
Mar 25, 2014
PDF 17.8 KB Add to Briefcase
View Summary BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy
Mar 20, 2014
PDF 15.6 KB Add to Briefcase
View Summary BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results
Mar 20, 2014
PDF 27.2 KB Add to Briefcase
View Summary BG Medicine Announces Fiscal Year 2013 Financial Results Release Date and Conference Call Information
Mar 13, 2014
PDF 13.4 KB Add to Briefcase
View Summary BG Medicine Welcomes La Jolla Pharmaceutical Company's Announcement of Positive Top-Line Results of Phase 2 Clinical Trial of Novel Pharmaceutical Compound Targeting Galectin-3 in Chronic Kidney Disease
Mar 12, 2014
PDF 16.8 KB Add to Briefcase
View Summary BG Medicine Compliant With NASDAQ Listing Requirements
Mar 11, 2014
PDF 11.9 KB Add to Briefcase
View Summary BG Medicine Welcomes Inclusion of Galectin-3 in 2014 Indian Consensus Document on Cardiac Biomarkers
Mar 10, 2014
PDF 17.8 KB Add to Briefcase
View Summary Automated VIDAS(R) Galectin-3 Assay Validated in Published Clinical Research Study
Jan 28, 2014
PDF 18.0 KB Add to Briefcase
View Summary BG Medicine to Transfer to the NASDAQ Capital Market; Obtains Requested NASDAQ Extension
Jan 27, 2014
PDF 16.1 KB Add to Briefcase
View Summary BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test
Dec 10, 2013
PDF 17.7 KB Add to Briefcase
View Summary Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure
Nov 19, 2013
PDF 17.6 KB Add to Briefcase
Showing 1-20 of 183 Page: 1 2 3 4 5 ... 10  Next 20
Add to Briefcase = add release to Briefcase